Phibro Animal Health (PAHC) Net Income towards Common Stockholders Growth (3y) (2015 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Net Income towards Common Stockholders Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn | 14.70% |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn | -0.23% |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 36.74% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 36.15% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 49.33% |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -350.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.15% |
| Mar 31, 2026 | 33.74% |
| Dec 31, 2025 | 56.16% |
| Sep 30, 2025 | 90.19% |
| Jun 30, 2025 | 23.11% |
| Mar 31, 2025 | 5.68% |
| Dec 31, 2024 | -43.29% |
| Sep 30, 2024 | 2.20% |
| Jun 30, 2024 | -8.15% |
| Mar 31, 2024 | -11.59% |
| Dec 31, 2023 | -53.66% |
| Sep 30, 2023 | -38.41% |
| Jun 30, 2023 | -0.70% |
| Mar 31, 2023 | -9.40% |
| Dec 31, 2022 | -15.37% |
| Sep 30, 2022 | 15.31% |
| Jun 30, 2022 | -8.77% |
| Mar 31, 2022 | 6.01% |
| Dec 31, 2021 | 5.80% |
| Sep 30, 2021 | -26.29% |